enzh-TWfrdeitjaptrues

The Dana-Farber Bing Center for Waldenstrom's Macroglobulinemia Web site is intended to provide general information about the program, its care and research programs, and about Waldenstrom's Macroglobulinemia and related diseases. This site also provides links to health information that may be written by Dana-Farber staff or by outside providers, and access (links) to some external Web sites for your convenience. The Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible for the availability, accuracy, or content of these external sites, nor does it endorse them.

No Medical Advice Given
This site is not an attempt to practice medicine or provide specific medical advice, nor does the use of the site establish a doctor-patient relationship. For medical treatment or answers to personal questions, we strongly encourage you to consult with a qualified health care provider. For advice about your own care, please ask your doctor!

Restrictions on Use
You assume full responsibility for using the information on this site, and you understand and agree that the Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible or liable for any claim, loss, or damage resulting from its use. While we try to keep the information on the site as accurate as possible, we disclaim any warranty concerning its accuracy, timeliness, and completeness, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose. The Dana-Farber Waldenstrom's Macroglobulinemia Program also does not warrant that access to the site will be error- or virus-free.

Copyright Infringement
Material on the Dana-Farber Waldenstrom's Macroglobulinemia Program Web site is protected by copyright law. Unless otherwise stated, users may print or download information from this site for personal, non-commercial use only. Permission to reprint or otherwise reproduce any document in whole or in part is prohibited, unless prior written consent is obtained from the copyright owner.

Latest Bing Center News

Latest News in the Treatment of WM - TELECONFERENCE 3/19/2020

Latest News in the Treatment of WM - TELECONFERENCE 3/19/2020

CancerCare, in association with the IWMF, is holding a Teleconference titled –  The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia on Thursday, March 19th  from 1:10-2:30  pm Eastern Time (ET). Presenting will be Steven Treon, MD, Ph.D, Christian Buske, MD, Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW, and Carl Harrington (IWMF).

Read more..

25th Annual IWMF Educational Forum

25th Annual IWMF Educational Forum

25th Annual IWMF Educational ForumJune 5-7, 2020Renton, WA"2020 Vision: A World Without WM"

Read more..

Steven Treon, MD, PhD to serve as advisor to IWMF Board

Steven Treon, MD, PhD to serve as advisor to IWMF Board

Dr. Steven Treon, MD, PhD, (Dana-Farber Cancer Institute) has agreed to advise the IWMF Board of Trustees. Dr. Treon joins Dr. Ansell of the Mayo Clinic in providing the critical perspective of world-renowned clinicians/researchers to the IWMF Board. Dr. Treon and Dr. Ansell also will jointly co-chair the IWMF Scientific Advisory Committee.

Read more..

Florida Blood Cancer Conference 2020 (LLS)

Florida Blood Cancer Conference 2020 (LLS)

Dr. Steven Treon will be lecturing at the upcoming Blood Cancer Conference (BCC), one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, survivors, families and oncology professionals, the people who deal with blood cancer every day and the people who care for them. BCC attendees receive the most current information and access to local resources to help navigate and make informed decisions about their treatment and survivorship.

Read more..

ASH 2019 - Bing Center Presentations

ASH 2019 - Bing Center Presentations

The ASH 2019 conference was held in Orlando, FL from December 7-10, 2019. Researchers from the Bing Center contributed an oral presentation (Guang Yang), and three posters (Jorge Castill, and Xia Liu).  

Read more..

IWMF Adds Three Members to Scientific Advisory Committee

IWMF Adds Three Members to Scientific Advisory Committee

The IWMF is proud to welcome three new members to its Scientific Advisory Committee (SAC) chaired by Dr. Stephen Ansell of the Mayo Clinic and Dr. Steven Treon of the Dana-Farber Cancer Institute. The new members, Dr. Zachary Hunter from Dana-Farber, Boston, USA, Dr. Christian Buske from Ulm, Germany, and Dr. Monique Minnema of The Netherlands, were invited to participate because of their expertise in specific research areas identified by the IWMF-LLS Strategic Research Roadmap for WM.

Read more..

Dr. Edward Laane - Running for WM! (Part-2)

Dr. Edward Laane - Running for WM! (Part-2)

On November3, 2019, Dr. Edward Laane ran the Osaka Yodo River Half Marathon, to raise money for Waldenstrom's research. His pure running time was 2.26.07 with his official time listed at 2.31.0. As Dr. Laane recalls, "The run was difficult. It was sunny, and a little bit hot. The first part, 6.5 miles was a little easier. My time was approximately 1h 10 min, but the second part was very difficult. But I was thinking about the patients who have gone through so much treatment and this gave me more strength to finish.

Read more..

New Approaches to treating Waldenstrom's Macroglobulinemia

New Approaches to treating Waldenstrom's Macroglobulinemia

At the 2019 Lymphoma & Myeloma Congress, Steven Treon, MD, PhD, FACP, FRCP, Harvard University, Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, Massachusetts, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.

Read more..

Dr. Edward Laane - Running for WM!

Dr. Edward Laane - Running for WM!

Dr. Edward Laane is running in the Osaka Yodo River Citizens Marathon to raise money for Waldenstrom's research!

Read more..

IMW-17 Young Investigator Awards

IMW-17 Young Investigator Awards

Congratulations to the following Bing Center researchers for their Young Investigator Awards at the 17th International Workshop on Multiple Myeloma!

Read more..